| 5 |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
219: Reduction, Plasma 17beta-estradiol concentrations |
Nov 29, 2016 |
Mar 20, 2017 |
6 AOPs
|
| 9 |
8: Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity |
179: Decrease, Fatty acid β-oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 11 |
12: AchE Inhibition |
10: ACh Synaptic Accumulation |
Nov 29, 2016 |
Sep 10, 2023 |
4 AOPs
|
| 16 |
17: Altered expression of AHR/ARNT pathway-dependent genes |
317: Altered, Cardiovascular development/function |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 17 |
17: Altered expression of AHR/ARNT pathway-dependent genes |
80: Up Regulation, CYP1A1 |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 18 |
18: Activation, AhR |
17: Altered expression of AHR/ARNT pathway-dependent genes |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 19 |
18: Activation, AhR |
80: Up Regulation, CYP1A1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 23 |
97: Alkylation, DNA |
336: Increase, Heritable mutations in offspring |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 24 |
97: Alkylation, DNA |
155: Inadequate DNA repair |
Nov 29, 2016 |
Dec 10, 2019 |
3 AOPs
|
| 25 |
97: Alkylation, DNA |
185: Increase, Mutations |
Nov 29, 2016 |
Nov 29, 2016 |
2 AOPs
|
| 31 |
25: Agonism, Androgen receptor |
129: Reduction, Gonadotropins, circulating concentrations |
Nov 29, 2016 |
Mar 20, 2017 |
1 AOP
|
| 32 |
25: Agonism, Androgen receptor |
274: Reduction, Testosterone synthesis by ovarian theca cells |
Nov 29, 2016 |
Mar 20, 2017 |
1 AOP
|
| 36 |
28: Reduction, Angiogenesis |
110: Impairment, Endothelial network |
Nov 29, 2016 |
Jan 18, 2022 |
1 AOP
|
| 45 |
36: Inhibition, Aromatase |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
Nov 29, 2016 |
Nov 30, 2016 |
1 AOP
|
| 51 |
39: Increased Cholinergic Signaling |
360: Decrease, Population growth rate |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 59 |
49: Reduction, Ca and HCO3 transport to shell gland |
106: Reduction, Eggshell thickness |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 60 |
50: Increase, Ca++ (intracellular) |
178: Mitochondrial electron transport chain, disrupted |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 61 |
51: Inhibition, Ca++ ATPase |
50: Increase, Ca++ (intracellular) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 62 |
52: Decreased, Calcium influx |
341: Impairment, Learning and memory |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 66 |
54: Up Regulation, CD36 |
115: Increase, FA influx |
Nov 29, 2016 |
Mar 27, 2024 |
2 AOPs
|
| 67 |
55: Cell injury/death |
134: Increase, Kupffer cell activation |
Nov 29, 2016 |
Nov 29, 2016 |
6 AOPs
|
| 68 |
55: Cell injury/death |
265: Increase, HSC activation |
Nov 29, 2016 |
Apr 21, 2026 |
2 AOPs
|
| 69 |
57: Proliferation, Cell proliferation in the absence of cytotoxicity |
142: Hyperplasia, Hyperplasia |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 70 |
60: Induction, Chitin degradation and resorption |
238: Induction, Pre-mature molting |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 77 |
66: Activation, ChREBP |
89: Synthesis, De Novo Fatty Acid (FA) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|